The Munich Score: A Clinical Index to Predict Survival in Ambulatory Patients With Chronic Heart Failure in the Era of New Medical Therapies

Journal of Heart and Lung Transplantation

Volumn 27, Issue 2, 2008, Pages 222-228

  Stempfle, Hans Ulrich ^a,b   Alt, Andrea ^b   Stief, Jutta ^b   Siebert, Uwe ^c,d  

^a Asklepios Stadtklinik Bad Tölz   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART FAILURE; HEART SIZE; HEMODYNAMIC PARAMETERS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR END DIASTOLIC DIAMETER; MAJOR CLINICAL STUDY; MALE; MUNICH SCORE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

ADULT; AMBULATORY CARE; ANALYSIS OF VARIANCE; CHRONIC DISEASE; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EXERCISE TEST; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 38949207533     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.10.016     Document Type: Article

References (28)

1. Stevenson L.W., Steimle A.E., Fonarow G., et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 25 (1995) 163-170
2. Aaronson K.D., Schwartz J.S., Chen T., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95 (1997) 2660-2667
3. Butler J., Khadim G., Paul K., et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 43 (2004) 787-793
4. Lund L., Aaronson K., and Mancici D. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol 92 (2003) 1350-1354
5. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
6. 2-a simple yet enduring standard. Circulation 101 (2000) 1080-1082
7. Peterson L.R., Schechtman K.B., Ewald G.A., et al. The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant 22 (2003) 70-77
8. Pohwani A.L., Murali S., Mathier M.M., et al. Impact of β-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 22 (2003) 78-86
9. Levy W., Mozaffarian D., Linker D., et al. The Seattle heart failure model. Prediction of survival in heart failure. Circulation 113 (2006) 1424-1433
10. Cintron G., Johnson G., Francis G., Cobb F., and Cohn J.N. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation 87 suppl (1993) VI-17-VI-23
11. Florea V.G., Henein M.Y., Anker S.D., et al. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J 21 (2000) 146-153
12. Grigioni F., Barbieri A., Magnani G., et al. Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications. Am Heart 146 (2003) 298-303
13. Sutcliffe P., Aaronson K., Cody R., and Koelling T. Impact of serial changes in cardiac hemodynamics on exercise performance in patients with heart failure due to ischemic and nonischemic cardiomyopathy. Am J Cardiol 91 (2003) 164-168
14. Koelling T., Joseph S., and Aaronson K. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving β-blockers. J Heart Lung Transplant 23 (2004) 1414-1422
15. Zugck C., Haunstetter A., Kruger C., et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 39 (2002) 1615-1622
16. Swedberg K., Cleland J., Dargie H., et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
17. The RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. The Randomized Aldactone Evaluation Study (RALES). Am J Cardiol 78 (1996) 902-907
18. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
19. Lee T.H., Hamilton M.A., Stevenson L.W., et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 72 (1993) 672-676
20. Hansen A., Haass M., Zugck C., et al. Prognostic value of doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 37 (2001) 1049-1055
21. Levine T.B., Levine A.B., Bolenbaugh J., and Stomel R.J. Impact of left ventricular size on pharmacologic reverse remodeling in heart failure. Clin Cardiol 23 (2000) 355-358
22. Lim E., Ali Z., Ali A., et al. Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure. J Heart Lung Transplant 24 (2005) 983-989
23. Stevenson W.G., Stevenson L.W., Middlekauff H.R., et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26 (1995) 1417-1423
24. Gullestad L., Myers J., Ross H., et al. Serial exercise testing and prognosis in selected patients considered for cardiac transplantation. Am Heart J 135 (1998) 221-229
25. Fonarow G., Stevenson L., Walden J., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30 (1997) 725-732
26. Latini R., Masson S., Anand I., et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25 (2004) 292-299
27. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
28. Cowie M.R., Jourdain P., Maisel A., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718